NASDAQ · Healthcare · Biotechnology
Tenax Therapeutics, Inc.
TENX
Tenax Therapeutics, Inc. CEO Christopher T. Giordano · Market cap $49.7M.
$1.87
-0.04 · -1.97%
52w hi $19.4052w lo $1.31
Off 52w high 90.4%
66
NOTABLE
Current InsiderScore
Corp · 90d
8
8 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
0 strong · 4 notable
Analyst consensus
Strong Buy
Avg PT $4.40
Section 01
Recent Form 4 filings
11 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 16 | Declan Doogan | Buy | 53,000 | $1.92 | +$102K | 63 | |
| Sep 03 | ADAR1 Capital Management, LLC | Buy | 900,000 | $1.78 | +$1.60M | 66 | |
| Sep 02 | ADAR1 Capital Management, LLC | Buy | 187,704 | $1.80 | +$338K | 54 | |
| Sep 01 | ADAR1 Capital Management, LLC | Buy | 179,058 | $1.80 | +$322K | 54 | |
| Aug 31 | ADAR1 Capital Management, LLC | Buy | 403,571 | $1.79 | +$723K | 60 | |
| Aug 24 | ADAR1 Capital Management, LLC | Buy | 107,374 | $1.75 | +$188K | 54 | |
| Aug 21 | ADAR1 Capital Management, LLC | Buy | 716,369 | $1.77 | +$1.27M | 66 | |
| Aug 20 | ADAR1 Capital Management, LLC | Buy | 202,124 | $1.78 | +$360K | 57 | |
| Dec 09 | Stuart Rich | Chief Medical Officer | Buy | 2,500 | $10.22 | +$26K | 50 |
| Dec 08 | Stuart Rich | Chief Medical Officer | Buy | 2,500 | $10.10 | +$25K | 50 |
| Nov 17 | Thomas Mcgauley | Interim CFO | Buy | 5,000 | $7.23 | +$36K | 56 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct